Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients

Several therapeutic regimens for COVID-19 have been studied, such as combination antiviral therapies. We aimed to compare outcome of two types of combination therapies atazanavir/ritonavir (ATV/r) or lopinavir/ritonavir (LPV/r) plus hydroxychloroquine among COVID-19 patients. 108 patients with moder...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazaherpour, Hossein, Sofian, Masoomeh, Farahani, Elham, Abdi, Alireza, Mazaherpour, Sakine, Bavand, Anahita, Ramezani, Amitis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742149/
https://www.ncbi.nlm.nih.gov/pubmed/35013710
http://dx.doi.org/10.1155/2022/1522426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742149/
https://www.ncbi.nlm.nih.gov/pubmed/35013710
http://dx.doi.org/10.1155/2022/1522426

Ejemplares similares